News

The future of treating diabetes – report from the 14th “What’s New in Diabetes” conference

Bioton partnerem Medycyna Trzech Tenorów

MEDICINE OF THE THREE TENORS – SCIENTIFIC AND TRAINING SYMPOSIA WITH THE PARTICIPATION OF BIOTON S.A

Bioton prezentuje GensuPen2 na konferencji w San Francisco

BIOTON S.A. PRESENTS THE RESULTS OF THE GENSUPEN2 RESEARCH PROGRAMME AT A CONFERENCE IN SAN FRANCISCO

Robert Neymann, prezes Bioton S. A. wśród prelegentów kongresu Impact’19

ROBERT NEYMANN, PRESIDENT OF BIOTON S.A., AMONG THE SPEAKERS OF THE IMPACT’19 CONGRESS

Bioton S.A. wśród spółek objętych Pilotażowym Programem Wsparcia Pokrycia Analitycznego GPW

BIOTON S.A. AMONG COMPANIES COVERED BY THE WSE ANALYTICAL COVERAGE PROGRAMME